ATE415480T1 - B7l-1 moleküle - Google Patents
B7l-1 moleküleInfo
- Publication number
- ATE415480T1 ATE415480T1 AT99942040T AT99942040T ATE415480T1 AT E415480 T1 ATE415480 T1 AT E415480T1 AT 99942040 T AT99942040 T AT 99942040T AT 99942040 T AT99942040 T AT 99942040T AT E415480 T1 ATE415480 T1 AT E415480T1
- Authority
- AT
- Austria
- Prior art keywords
- molecules
- polypeptides
- purified
- preparing
- directed
- Prior art date
Links
- 108020004635 Complementary DNA Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9566398P | 1998-08-07 | 1998-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE415480T1 true ATE415480T1 (de) | 2008-12-15 |
Family
ID=22253041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99942040T ATE415480T1 (de) | 1998-08-07 | 1999-08-05 | B7l-1 moleküle |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US6512095B2 (de) |
| EP (1) | EP1108042B1 (de) |
| AT (1) | ATE415480T1 (de) |
| AU (1) | AU771640B2 (de) |
| CA (1) | CA2337712A1 (de) |
| DE (1) | DE69939982D1 (de) |
| ES (1) | ES2315016T3 (de) |
| IL (3) | IL140938A0 (de) |
| NZ (1) | NZ510357A (de) |
| WO (1) | WO2000008057A2 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2337100C (en) * | 1998-08-07 | 2011-09-20 | Immunex Corporation | Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| WO2000008057A2 (en) * | 1998-08-07 | 2000-02-17 | Immunex Corporation | Molecules designated b7l-1 |
| US20030144478A1 (en) * | 2001-02-06 | 2003-07-31 | Immunex Corporation | Molecules designated B7L-1 |
| AU2588000A (en) * | 1998-12-02 | 2000-06-19 | Icos Corporation | Novel adhesion molecule and methods of use |
| US7129338B1 (en) * | 1999-07-08 | 2006-10-31 | Research Association For Biotechnology | Secretory protein or membrane protein |
| EP1514933A1 (de) * | 1999-07-08 | 2005-03-16 | Research Association for Biotechnology | Sekretorische- oder Membranproteine |
| AU8026500A (en) * | 1999-10-18 | 2001-04-30 | Texas Biotechnology Corporation | Polynucleotides encoding human and murine adhesion proteins (bigr) |
| US6965018B2 (en) | 2000-06-06 | 2005-11-15 | Bristol-Myers Squibb Company | Antibodies directed to B7-related polypeptide, BSL-2 |
| AU2001271618B8 (en) * | 2000-06-28 | 2006-04-27 | Amgen, Inc. | B7-Like molecules and uses thereof |
| JP4435563B2 (ja) * | 2001-07-10 | 2010-03-17 | バイオジェン アイデック インク | アポトーシスプロセスの阻害および細胞性能の改善 |
| JP2003116561A (ja) * | 2001-10-11 | 2003-04-22 | National Cancer Center-Japan | Tsll1遺伝子 |
| US20040053307A1 (en) * | 2002-06-17 | 2004-03-18 | Wyeth | Inhibition of T cell activation by butyrophilin 4 and B7-L1 |
| JP2007500132A (ja) * | 2003-07-25 | 2007-01-11 | アムジェン インコーポレイテッド | Ldcamのアンタゴニストおよびアゴニスト、並びにその使用法 |
| DE602007009954D1 (de) | 2006-03-22 | 2010-12-02 | Viral Logic Systems Technology | Verfahren zur identifizierung von polypeptid-targets |
| EP2069793B9 (de) | 2006-08-29 | 2017-08-16 | Oxford BioTherapeutics Ltd | Identifizierung von mit hepatozellulärem karzinom, glioblastom und lungenkrebs assoziiertem protein |
| JP5816558B2 (ja) | 2009-03-05 | 2015-11-18 | メダレックス・リミテッド・ライアビリティ・カンパニーMedarex, L.L.C. | Cadm1に特異的な完全ヒト抗体 |
| UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| WO2014144817A2 (en) | 2013-03-15 | 2014-09-18 | Amgen Inc. | Inhibitory polypeptides specific to wnt inhibitors |
| WO2015017531A1 (en) * | 2013-07-30 | 2015-02-05 | H.B. Fuller Company | Polyurethane adhesive film |
| EP3712166A1 (de) | 2013-09-05 | 2020-09-23 | Amgen Inc. | Fc-haltige moleküle mit vorhersagbaren, konsistenten und reproduzierbaren glycoformprofilen |
| WO2015175861A1 (en) | 2014-05-16 | 2015-11-19 | Amgen Inc. | Assay for detecting th1 and th2 cell populations |
| AU2018235928B2 (en) | 2017-03-14 | 2023-09-21 | Amgen Inc. | Control of total afucosylated glycoforms of antibodies produced in cell culture |
| US12325737B2 (en) | 2018-03-26 | 2025-06-10 | Amgen Inc. | Total afucosylated glycoforms of antibodies produced in cell culture |
| KR20220069982A (ko) | 2019-09-26 | 2022-05-27 | 암젠 인크 | 항체 조성물의 생산 방법 |
| EP4045515A4 (de) | 2019-10-18 | 2023-10-18 | The Regents Of The University Of Michigan | Biomaterialsensorsysteme |
| WO2021247892A1 (en) | 2020-06-04 | 2021-12-09 | Amgen Inc. | Assessment of cleaning procedures of a biotherapeutic manufacturing process |
| US20240043501A1 (en) | 2020-10-15 | 2024-02-08 | Amgen Inc. | Relative unpaired glycans in antibody production methods |
| AU2022289365A1 (en) | 2021-06-07 | 2023-12-14 | Amgen Inc. | Using fucosidase to control afucosylation level of glycosylated proteins |
| JP2024537100A (ja) | 2021-10-05 | 2024-10-10 | アムジエン・インコーポレーテツド | Fcガンマ受容体II結合、及びグリカン含量 |
| WO2023215725A1 (en) | 2022-05-02 | 2023-11-09 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
| JP2026516670A (ja) | 2023-04-20 | 2026-05-26 | アムジエン・インコーポレーテツド | 相対的な不対グリカン含有量を決定する方法 |
| AU2024325342A1 (en) | 2023-08-14 | 2026-02-26 | Amgen Inc. | Methods for reducing yellow color |
| WO2025101820A1 (en) | 2023-11-08 | 2025-05-15 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
| WO2026090253A1 (en) | 2024-10-23 | 2026-04-30 | Amgen Inc. | Methods of determining glycan pairing content |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218510B1 (en) | 1994-03-02 | 2001-04-17 | Brigham & Woman's Hospital | B7-1 and B7-2 polypeptides |
| CA2285447A1 (en) | 1997-03-28 | 1998-10-08 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| WO1998044113A1 (en) * | 1997-03-28 | 1998-10-08 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| EP1039801A4 (de) | 1997-06-06 | 2003-03-26 | Human Genome Sciences Inc | 207 menschliche sekretierte proteine |
| NZ503343A (en) | 1997-09-17 | 2002-09-27 | Genentech Inc | Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells |
| EP0939124A3 (de) | 1998-02-24 | 2001-03-21 | Smithkline Beecham Plc | MBGP1-Sequenzen |
| WO2000008057A2 (en) * | 1998-08-07 | 2000-02-17 | Immunex Corporation | Molecules designated b7l-1 |
| AU2588000A (en) | 1998-12-02 | 2000-06-19 | Icos Corporation | Novel adhesion molecule and methods of use |
| AU2600800A (en) | 1999-03-08 | 2000-09-28 | Genentech Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
| CN1242376A (zh) | 1999-07-27 | 2000-01-26 | 中国医学科学院基础医学研究所 | 人神经系统特异表达基因 |
-
1999
- 1999-08-05 WO PCT/US1999/017906 patent/WO2000008057A2/en not_active Ceased
- 1999-08-05 EP EP99942040A patent/EP1108042B1/de not_active Expired - Lifetime
- 1999-08-05 NZ NZ510357A patent/NZ510357A/xx not_active IP Right Cessation
- 1999-08-05 IL IL14093899A patent/IL140938A0/xx unknown
- 1999-08-05 ES ES99942040T patent/ES2315016T3/es not_active Expired - Lifetime
- 1999-08-05 AT AT99942040T patent/ATE415480T1/de not_active IP Right Cessation
- 1999-08-05 DE DE69939982T patent/DE69939982D1/de not_active Expired - Lifetime
- 1999-08-05 CA CA002337712A patent/CA2337712A1/en not_active Abandoned
- 1999-08-05 AU AU55504/99A patent/AU771640B2/en not_active Ceased
-
2001
- 2001-01-17 IL IL140938A patent/IL140938A/en not_active IP Right Cessation
- 2001-02-06 US US09/778,510 patent/US6512095B2/en not_active Expired - Fee Related
-
2007
- 2007-10-31 US US11/981,954 patent/US20080075724A1/en not_active Abandoned
-
2009
- 2009-01-14 IL IL196509A patent/IL196509A/en not_active IP Right Cessation
-
2010
- 2010-02-26 US US12/714,246 patent/US7939640B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1108042B1 (de) | 2008-11-26 |
| NZ510357A (en) | 2004-02-27 |
| US6512095B2 (en) | 2003-01-28 |
| IL140938A0 (en) | 2002-02-10 |
| DE69939982D1 (de) | 2009-01-08 |
| IL196509A (en) | 2011-04-28 |
| AU5550499A (en) | 2000-02-28 |
| EP1108042A2 (de) | 2001-06-20 |
| US7939640B2 (en) | 2011-05-10 |
| US20020164686A1 (en) | 2002-11-07 |
| ES2315016T3 (es) | 2009-03-16 |
| AU771640B2 (en) | 2004-04-01 |
| IL196509A0 (en) | 2009-09-22 |
| US20080075724A1 (en) | 2008-03-27 |
| IL140938A (en) | 2010-12-30 |
| US20100168399A1 (en) | 2010-07-01 |
| CA2337712A1 (en) | 2000-02-17 |
| WO2000008057A2 (en) | 2000-02-17 |
| WO2000008057A3 (en) | 2000-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69939982D1 (de) | B7l-1 moleküle | |
| ATE484587T1 (de) | Ldcam genannte moleküle | |
| DE69836088D1 (de) | Als lerk6 bezeichnetes cytokin | |
| BR9814404A (pt) | " clonagem de expressão em fungos filamentosos " | |
| DE69131580D1 (de) | GDF-1 und UOG1 Proteine | |
| CY1108175T1 (el) | ΠΟΛΥΠΕΠΤΙΔΙΟ DcR3, ΟΜΟΛΟΓΟ TNFR | |
| DK1015586T3 (da) | TIE-receptortyrosinkinaseligandhomologer | |
| DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
| WO2000018914A3 (en) | Novel dkr polypeptides | |
| DE68914664D1 (de) | Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden. | |
| ATE384787T1 (de) | Tripeptidyl-aminopeptidase | |
| DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
| ATE310085T1 (de) | Cyclin-e2 proteine und dafür kodierende gene | |
| DE69535316D1 (de) | Als lerk6 bezeichnetes cytokin | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| ATE408687T1 (de) | Semaphorin polypeptide | |
| FI902803A7 (fi) | DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä | |
| HUP9901123A2 (hu) | ICAM-4 anyagok és módszerek | |
| EP0676413A3 (de) | Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung. | |
| DE59911530D1 (de) | Zellpermeabilität-vermittelndes polypeptid | |
| ZA99445B (en) | Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof. | |
| HK1031229A (en) | Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof | |
| DK199900148A (da) | Enzym samt DNA-sekvens, der koder for dette | |
| ATE104344T1 (de) | Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |